Role of Fork-Head Box Genes in Breast Cancer: From Drug Resistance to Therapeutic Targets

Breast cancer has been acknowledged as one of the most notorious cancers, responsible for millions of deaths around the globe. Understanding the various factors, genetic mutations, comprehensive pathways, etc., that are involved in the development of breast cancer and how these affect the development of the disease is very important for improving and revitalizing the treatment of this global health issue. The forkhead-box gene family, comprising 19 subfamilies, is known to have a significant impact on the growth and progression of this cancer. The article looks into the various forkhead genes and how they play a role in different types of cancer. It also covers their impact on cancer drug resistance, interaction with microRNAs, explores their potential as targets for drug therapies, and their association with stem cells.

[1]  G. Tanriover,et al.  SIRT1/FOXO Signaling Pathway in Breast Cancer Progression and Metastasis , 2022, International journal of molecular sciences.

[2]  Hao Liu,et al.  Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer , 2021, Nature Communications.

[3]  S. Taheri,et al.  MicroRNA profiling identifies Forkhead transcription factor M1 (FOXM1) regulated miR-186 and miR-200b alterations in triple negative breast cancer. , 2021, Cellular signalling.

[4]  Yingqi Zhang,et al.  Forkhead box P3 promotes breast cancer cell apoptosis by regulating programmed cell death 4 expression , 2020, Oncology letters.

[5]  Hong-Sheng Zhang,et al.  FOXM1 facilitates breast cancer cell stemness and migration in YAP1-dependent manner. , 2020, Archives of biochemistry and biophysics.

[6]  Sang Kook Lee,et al.  The potential impacts of tylophora alkaloids and their derivatives in modulating inflammation, viral infections, and cancer. , 2019, Current medicinal chemistry.

[7]  Hao Liu,et al.  Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis , 2019, Cell Death & Differentiation.

[8]  Xiaolong Guo,et al.  MicroRNA-937 inhibits the malignant phenotypes of breast cancer by directly targeting and downregulating forkhead box Q1 , 2019, OncoTargets and therapy.

[9]  Chi Wang,et al.  Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer , 2018, Nature Communications.

[10]  Nguyen Phuoc Long,et al.  The Dominant Role of Forkhead Box Proteins in Cancer , 2018, International journal of molecular sciences.

[11]  R. Nahta,et al.  Targeting forkhead box M1 transcription factor in breast cancer , 2018, Biochemical pharmacology.

[12]  R. Yadav,et al.  FoxO transcription factors in cancer metabolism. , 2018, Seminars in cancer biology.

[13]  Sang Kook Lee,et al.  Long noncoding RNAs in cancer cells. , 2018, Cancer letters.

[14]  Lei Zheng,et al.  Emerging roles and mechanisms of FOXC2 in cancer. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[15]  Shu-Ming Sun,et al.  FoxM1 is a promising candidate target in the treatment of breast cancer , 2017, Oncotarget.

[16]  Jun Chen,et al.  MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2. , 2017, Cancer biomarkers : section A of Disease markers.

[17]  E. Lam,et al.  The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance , 2017, Seminars in cancer biology.

[18]  M. Boerries,et al.  SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells , 2017, PLoS genetics.

[19]  Dahai Liu,et al.  Inhibition of Wnt/β-catenin signaling by IWR1 induces expression of Foxd3 to promote mouse epiblast stem cell self-renewal. , 2017, Biochemical and biophysical research communications.

[20]  Ning Duan,et al.  The Emerging Roles of Forkhead Box (FOX) Proteins in Osteosarcoma , 2017, Journal of Cancer.

[21]  Y. Nakayama,et al.  Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6 , 2017, The Journal of Biological Chemistry.

[22]  Lunquan Sun,et al.  The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells , 2017, Cell Death & Disease.

[23]  Pin Wu,et al.  Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis , 2017, Oncotarget.

[24]  A. Giuliano,et al.  FOXC1: an emerging marker and therapeutic target for cancer , 2017, Oncogene.

[25]  F. Pan,et al.  Foxp3, Regulatory T Cell, and Autoimmune Diseases , 2017, Inflammation.

[26]  Lijun Xue,et al.  FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10 , 2016, Oncotarget.

[27]  Łukasz Szylberg,et al.  The Role of FOXP3 in Human Cancers. , 2016, Anticancer research.

[28]  Ying Chen,et al.  miR-937 contributes to the lung cancer cell proliferation by targeting INPP4B. , 2016, Life sciences.

[29]  T. Kume,et al.  Foxc1 Regulates Early Cardiomyogenesis and Functional Properties of Embryonic Stem Cell Derived Cardiomyocytes , 2016, Stem cells.

[30]  Y. Toiyama,et al.  FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer , 2016, Clinical Cancer Research.

[31]  Adrian V. Lee,et al.  Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide* , 2016, The Journal of Biological Chemistry.

[32]  Sung-Bae Kim,et al.  Expression of FOXM1 and related proteins in breast cancer molecular subtypes , 2016, International journal of experimental pathology.

[33]  Zhaoyu Li,et al.  FOXA1 defines cancer cell specificity , 2016, Science Advances.

[34]  J. Demoulin,et al.  FOXO transcription factors in cancer development and therapy , 2016, Cellular and Molecular Life Sciences.

[35]  E. Fuchs,et al.  FOXC1 maintains the hair follicle stem cell niche and governs stem cell quiescence to preserve long-term tissue-regenerating potential , 2016, Proceedings of the National Academy of Sciences.

[36]  B. Ozpolat,et al.  FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells , 2016, Oncotarget.

[37]  Hisashi Tanaka,et al.  FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance , 2016, Oncogene.

[38]  Yonghao Yu,et al.  Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling , 2016, Nature Cell Biology.

[39]  J. Sebat,et al.  FOXP1-related intellectual disability syndrome: a recognisable entity , 2017, Journal of Medical Genetics.

[40]  M. Bullock,et al.  FOXO factors and breast cancer: outfoxing endocrine resistance. , 2016, Endocrine-related cancer.

[41]  E. Lam,et al.  Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance , 2016, Current drug targets.

[42]  C. Logothetis,et al.  Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties , 2016, Oncogene.

[43]  Su In Lee,et al.  FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells , 2015, Oncotarget.

[44]  K. L. Silva,et al.  FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance. , 2015, Cellular signalling.

[45]  Xin Du,et al.  FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer. , 2015, Cancer letters.

[46]  Xiuwen Yu,et al.  miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer. , 2015, International journal of clinical and experimental pathology.

[47]  K. Bae,et al.  FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function. , 2015, Gastroenterology.

[48]  M. Walter,et al.  FOXC1, the new player in the cancer sandbox , 2015, Oncotarget.

[49]  Hongyan Chen,et al.  Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma , 2015, Journal of Cancer Research and Clinical Oncology.

[50]  Lara J. Monteiro,et al.  Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance , 2015, Oncogene.

[51]  Yi Zhao,et al.  MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells’ growth and migration , 2015, Tumor Biology.

[52]  Yuan Yang,et al.  A Double-Negative Feedback Loop between MicroRNA-422 a and FOXG 1 / Q 1 / E 1 Regulates Hepatocellular Carcinoma Tumor Growth and Metastasis , 2014 .

[53]  Guojun Wu,et al.  PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance. , 2015, Cancer research.

[54]  Hongyan Li,et al.  Transcriptional Regulation by FOXP1, FOXP2, and FOXP4 Dimerization , 2015, Journal of Molecular Neuroscience.

[55]  Hong Yue,et al.  FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27. , 2015, Biochemical and biophysical research communications.

[56]  A. Dopazo,et al.  A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes , 2014, Breast Cancer Research.

[57]  De Chen,et al.  MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1 , 2014, BMC Cancer.

[58]  E. Lam,et al.  Forkhead Box Transcription Factors in Cancer Initiation, Progression and Chemotherapeutic Drug Response , 2014, Front. Oncol..

[59]  Cheng-Wen Wu,et al.  FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells , 2014, Oncotarget.

[60]  T. Kume,et al.  Foxc1 is a critical regulator of haematopoietic stem/progenitor cell niche formation , 2014, Nature.

[61]  Lara J. Monteiro,et al.  FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance , 2013, Oncogene.

[62]  Jan J. Brosens,et al.  Forkhead box proteins: tuning forks for transcriptional harmony. , 2013, Nature reviews. Cancer.

[63]  F. Pontén,et al.  Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling. , 2013, Gastroenterology.

[64]  D. Fan,et al.  Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma , 2013, Hepatology.

[65]  Jeffrey T. Chang,et al.  FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. , 2013, Cancer research.

[66]  Shankar Balasubramanian,et al.  Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells , 2013, Genome Biology.

[67]  Zhaoyu Li,et al.  Foxa2 and H2A.Z Mediate Nucleosome Depletion during Embryonic Stem Cell Differentiation , 2012, Cell.

[68]  Lara J. Monteiro,et al.  The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment , 2012, Oncogene.

[69]  Shahrokh F. Shariat,et al.  Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation , 2012, PloS one.

[70]  J. Carroll,et al.  Pioneer transcription factors: establishing competence for gene expression. , 2011, Genes & development.

[71]  David E A Kloet,et al.  The PKB/FOXO switch in aging and cancer. , 2011, Biochimica et biophysica acta.

[72]  T. Hickey,et al.  FOXA1: master of steroid receptor function in cancer , 2011, The EMBO journal.

[73]  Valerie Speirs,et al.  ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer. , 2011, The American journal of pathology.

[74]  B. Bao,et al.  Over‐expression of FoxM1 leads to epithelial–mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells , 2011, Journal of cellular biochemistry.

[75]  J. Paik,et al.  FoxO family members in cancer , 2011, Cancer biology & therapy.

[76]  Hyun Jung Park,et al.  FoxM1: a master regulator of tumor metastasis. , 2011, Cancer research.

[77]  N. Hay,et al.  Deregulation of FoxM1b leads to tumour metastasis , 2011, EMBO molecular medicine.

[78]  F. Ghiringhelli,et al.  Human FOXP3 and cancer , 2010, Oncogene.

[79]  Brian C. Jackson,et al.  Update of human and mouse forkhead box (FOX) gene families , 2010, Human Genomics.

[80]  A. Giuliano,et al.  FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. , 2010, Cancer research.

[81]  J. McManaman,et al.  Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-i receptor in breast cancer cells resistant to herceptin. , 2010, Cancer research.

[82]  Lara J. Monteiro,et al.  FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells , 2010, Molecular Cancer Research.

[83]  N. Hay,et al.  FoxM1, a critical regulator of oxidative stress during oncogenesis , 2009, The EMBO journal.

[84]  K. Maiese,et al.  Clever cancer strategies with FoxO transcription factors , 2008, Cell cycle.

[85]  S. Badve,et al.  Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications , 2008, Journal of Clinical Pathology.

[86]  C. Shapiro,et al.  Sensitizing estrogen receptor–negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor , 2008, Molecular Cancer Therapeutics.

[87]  A. Gartel,et al.  FOXM1: The Achilles' heel of cancer? , 2008, Nature Reviews Cancer.

[88]  Arndt Hartmann,et al.  Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer , 2008, BMC Cancer.

[89]  K. Walsh,et al.  Forkhead Transcription Factors and Cardiovascular Biology , 2007 .

[90]  E. Greer,et al.  FOXO transcription factors in ageing and cancer , 2007, Acta physiologica.

[91]  D. Tindall,et al.  Dynamic FoxO transcription factors , 2007, Journal of Cell Science.

[92]  A. Banham,et al.  FOXP1: a potential therapeutic target in cancer , 2007, Expert opinion on therapeutic targets.

[93]  S. Badve,et al.  FOXA1 as a therapeutic target for breast cancer , 2007, Expert opinion on therapeutic targets.

[94]  Vladimir Petrovic,et al.  A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. , 2007, The Journal of clinical investigation.

[95]  D. Guertin,et al.  Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.

[96]  A. Gartel,et al.  Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1. , 2006, Cancer research.

[97]  E. Lam,et al.  The Forkhead Box M1 Protein Regulates the Transcription of the Estrogen Receptor α in Breast Cancer Cells* , 2006, Journal of Biological Chemistry.

[98]  K. Kaestner,et al.  The Foxa family of transcription factors in development and metabolism , 2006, Cellular and Molecular Life Sciences CMLS.

[99]  Myles A Brown,et al.  Estrogen receptor target gene: an evolving concept. , 2006, Molecular endocrinology.

[100]  K. McMasters,et al.  Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cells , 2006, Cancer biology & therapy.

[101]  R. Jove,et al.  Expression and role of Foxa proteins in prostate cancer , 2006, The Prostate.

[102]  P. Hegde,et al.  A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[103]  Zhiyuan Hu,et al.  Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[104]  Vladimir Petrovic,et al.  Forkhead Box M1 Regulates the Transcriptional Network of Genes Essential for Mitotic Progression and Genes Encoding the SCF (Skp2-Cks1) Ubiquitin Ligase , 2005, Molecular and Cellular Biology.

[105]  Céline Lefebvre,et al.  From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[106]  Clifford A. Meyer,et al.  Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1 , 2005, Cell.

[107]  M. Follettie,et al.  Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. , 2005, Cancer research.

[108]  P. Coffer,et al.  Forkhead-box transcription factors and their role in the immune system , 2004, Nature Reviews Immunology.

[109]  G Leclercq,et al.  About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-α gene (ESR1) in breast cancer , 2004, Molecular and Cellular Endocrinology.

[110]  P. Carlsson,et al.  Forkhead transcription factors: key players in development and metabolism. , 2002, Developmental biology.

[111]  Simak Ali,et al.  Endocrine-responsive breast cancer and strategies for combating resistance , 2002, Nature Reviews Cancer.

[112]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[113]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[114]  Xiang-jin Zheng,et al.  Members of FOX family could be drug targets of cancers , 2018, Pharmacology & therapeutics.

[115]  T. Cotter,et al.  New Insight into the Role of Reactive Oxygen Species (ROS) in Cellular Signal-Transduction Processes. , 2015, International review of cell and molecular biology.

[116]  T. Kume.  The cooperative roles of Foxc1 and Foxc2 in cardiovascular development. , 2009, Advances in experimental medicine and biology.

[117]  David E. Misek,et al.  The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. , 2002, Cancer research.